Physician profile
Leslie E Irvine
NPI 1376983429
$2,880.15
in general payments reported to CMS, 2019-2025
12 companies · $995 in 2025
The $995 reported for 2025 was more than what 86% of Facial Plastic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $242 · 2021: $93.09 · 2022: $299 · 2023: $476 · 2024: $508 · 2025: $995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,962 · Education: $16.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,961.77 |
| Education | $16.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,169.20 | 2022-2025 | |
| Axogen | $368.04 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Baxter Healthcare | $282.45 | 2024-2025 | Perclot |
| Galderma Laboratories, L.P. | $257.30 | 2019-2020 | |
| Merz Pharmaceuticals, LLC | $149.91 | 2022 | |
| Acclarent, INC | $136.91 | 2023 | Relieva Spinplus, Acclarent Aera, Trudi Nav Cable |
| Integra Lifesciences Corporation | $135.47 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Stryker Corporation | $130.35 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $96.40 | 2019 | |
| Boston Scientific Corporation | $63.53 | 2019-2021 | |
| Aerin Medical INC. | $51.51 | 2021-2022 | |
| Medtronic USA, INC. | $39.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Irvine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.